1. Burns, J. J., Cucinell, S. A., Koster, R., Conney, H.: Application of drug metabolism to drug toxicity studies. Ann. N. Y. Acad. Sci. 123, 273 (1965).
2. Christiansen, J.: Assay of carbamazepine and metabolites in plasma by quantitative thin-layer chromatography. In: Methods of analysis of antiepileptic drugs. (Eds. J. W. A. Meijer, H. Meinardi, C. Gardner-Thorpe, E. van der Kleijn), ICS 286, 87. Amsterdam: Excerpta Medica, New York: American Elsevier Co., Inc. 1973.
3. Christiansen, J., Dam, M.: Influence of phenobarbital and diphenylhydantoin on plasma carbamazepine levels in patients with epilepsy. Acta neurol. scand. 49, 543 (1973).
4. Cucinell, S. A., Conney, A. H., Sansur, M., Burns, J. J.: Drug interactions in man. I. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin and diphenylhydantoin. Clin. Pharmacol. Ther. 6, 420—429 (1965).
5. Harbison, R. D., Eling, T. E., Becker, B. A.: Effect of diphenylhydantoin on neonatal rat liver drug metabolising enzymes. Fed. Proc. 28, 676 (1969).